Therapeutics and COVID-19 – Living Guideline (2022) World Health Organization

Description

A living clinical guideline providing updated recommendations for the use of various therapeutics (including Molnupiravir, Janus kinase inhibitors, and Sotrovimab) in the management of COVID-19. This document includes specific sections on mechanism of action and guidance based on the WHO severity definitions.